-
EP4274585
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4274585
| EP4274585 - COMBINATION OF DEOXYRIBONUCLEASE ENZYME AND CELL THERAPIES FOR TREATMENT OF CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 13.10.2023 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 15.07.2022 | Most recent event Tooltip | 15.03.2024 | Change: Validation states | published on 17.04.2024 [2024/16] | 15.03.2024 | Change - extension states | published on 17.04.2024 [2024/16] | Applicant(s) | For all designated states CLS Therapeutics Limited Frances House, Sir William Place St. Peter Port Guernsey, Channel Islands, GY1 1GX / GG | [2023/46] | Inventor(s) | 01 /
GENKIN, Dmitry Dmitrievich Saint Petersburg, 197110 / RU | 02 /
TETS, Georgy Viktorovich New York, New York 10128 / US | 03 /
TETS, Viktor Veniaminovich New York, New York 10128 / US | 04 /
STEPANOV, Alexey Vyacheslavovich Moscow, 117342 / RU | [2023/46] | Representative(s) | Bandpay & Greuter 11 rue Christophe Colomb 75008 Paris / FR | [N/P] |
| Former [2023/46] | Bandpay & Greuter 30, rue Notre-Dame des Victoires 75002 Paris / FR | Application number, filing date | 22737186.1 | 07.01.2022 | [2023/46] | WO2022US11648 | Priority number, date | US202163135438P | 08.01.2021 Original published format: US 202163135438 P | US202163148304P | 11.02.2021 Original published format: US 202163148304 P | [2023/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022150609 | Date: | 14.07.2022 | Language: | EN | [2022/28] | Type: | A1 Application with search report | No.: | EP4274585 | Date: | 15.11.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.07.2022 takes the place of the publication of the European patent application. | [2023/46] | Search report(s) | International search report - published on: | US | 14.07.2022 | Classification | IPC: | A61K35/17, A61K38/17, A61K38/46, A61K38/47 | [2023/46] | CPC: |
A61K45/06 (EP);
A61K35/17 (US);
A61K2239/31 (EP,US);
A61K2239/38 (EP,US);
A61K2239/48 (EP,US);
A61K38/465 (EP,US);
A61K39/4611 (EP,US);
A61K39/4631 (EP,US);
A61K39/464412 (EP,US);
A61K39/464454 (US);
A61K39/464482 (EP,US);
A61K48/005 (US);
A61K9/0019 (EP,US);
A61P35/00 (EP,US);
C07K14/55 (EP);
C07K14/7051 (EP);
C07K14/70521 (EP);
C07K14/70578 (EP);
C07K16/2803 (US);
C12N15/86 (EP,US);
C12N5/0636 (EP,US);
C12N9/22 (EP,US);
C12Y301/21001 (EP,US);
A61K2239/13 (US);
C07K2319/00 (EP);
C07K2319/02 (EP);
C07K2319/03 (EP);
C07K2319/33 (EP);
C12N2510/00 (EP);
C12N2750/14143 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/46] | Title | German: | KOMBINATION AUS DESOXYRIBONUKLEASEENZYM UND ZELLTHERAPIEN ZUR BEHANDLUNG VON KREBS | [2023/46] | English: | COMBINATION OF DEOXYRIBONUCLEASE ENZYME AND CELL THERAPIES FOR TREATMENT OF CANCER | [2023/46] | French: | COMBINAISON D'ENZYME DÉSOXYRIBONUCLÉASE ET DE THÉRAPIES CELLULAIRES POUR LE TRAITEMENT DU CANCER | [2023/46] | Entry into regional phase | 08.08.2023 | National basic fee paid | 08.08.2023 | Search fee paid | 08.08.2023 | Designation fee(s) paid | 08.08.2023 | Examination fee paid | Examination procedure | 08.08.2023 | Examination requested [2023/46] | 01.03.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 25.01.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2019151365 (ANAK OEZLEM [FR], et al); | [XY]US2020323917 (FUCHS TOBIAS A [US], et al); | [Y]US2020399623 (BAIK ANDREW [US], et al) |